Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone650-241-7900
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$7.91 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date5/13/2019 (Estimated)
OptionableNot Optionable
Avinger (NASDAQ:AVGR) Frequently Asked Questions
What is Avinger's stock symbol?
Avinger trades on the NASDAQ under the ticker symbol "AVGR."
When did Avinger's stock split? How did Avinger's stock split work?
Avinger shares reverse split on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.
How were Avinger's earnings last quarter?
Avinger Inc (NASDAQ:AVGR) issued its quarterly earnings results on Wednesday, March, 6th. The medical device company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.29) by $0.02. The medical device company earned $2.03 million during the quarter. Avinger had a negative return on equity of 353.82% and a negative net margin of 358.74%. View Avinger's Earnings History.
When is Avinger's next earnings date?
Has Avinger been receiving favorable news coverage?
News headlines about AVGR stock have been trending somewhat positive this week, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Avinger earned a news sentiment score of 1.0 on InfoTrie's scale. They also assigned news headlines about the medical device company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future.
Are investors shorting Avinger?
Avinger saw a increase in short interest in the month of February. As of February 15th, there was short interest totalling 1,779,722 shares, an increase of 92.8% from the January 31st total of 923,295 shares. Based on an average daily trading volume, of 3,337,189 shares, the days-to-cover ratio is presently 0.5 days. Approximately 7.6% of the shares of the company are sold short. View Avinger's Current Options Chain.
Who are some of Avinger's key competitors?
Some companies that are related to Avinger include RenovaCare (RCAR), Sensus Healthcare (SRTS), Alphatec (ATEC), T2 Biosystems (TTOO), STRATA Skin Sciences (SSKN), Apollo Endosurgery (APEN), Endologix (ELGX), iCAD (ICAD), CAS Medical Systems (CASM), Invo Bioscience (IVOB), Titan Medical (TMDI), Arch Therapeutics (ARTH), Spectral Medical (EDTXF), Pro-Dex (PDEX) and Motus GI (MOTS).
What other stocks do shareholders of Avinger own?
Who are Avinger's key executives?
Avinger's management team includes the folowing people:
- Mr. Jeffrey M. Soinski, Pres, CEO & Director (Age 57)
- Mr. Mark B. Weinswig, Chief Financial Officer (Age 46)
- Mr. Himanshu N. Patel, Chief Technology Officer (Age 59)
- Mr. Keith Schaefer, Chief Operating Officer
- Mr. Philip R. Preuss, VP of Marketing & Bus. Operations (Age 41)
When did Avinger IPO?
(AVGR) raised $60 million in an IPO on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.
Who are Avinger's major shareholders?
Avinger's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Virtu Financial LLC (1.08%) and CVI Holdings LLC (0.63%). Company insiders that own Avinger stock include Himanshu Patel and John B Ph D Md Simpson. View Institutional Ownership Trends for Avinger.
Which major investors are buying Avinger stock?
How do I buy shares of Avinger?
Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Avinger's stock price today?
One share of AVGR stock can currently be purchased for approximately $0.88.
How big of a company is Avinger?
Avinger has a market capitalization of $37.22 million and generates $7.91 million in revenue each year. The medical device company earns $-27,560,000.00 in net income (profit) each year or ($3.34) on an earnings per share basis.
What is Avinger's official website?
How can I contact Avinger?
Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected]
MarketBeat Community Rating for Avinger (NASDAQ AVGR)
MarketBeat's community ratings are surveys of what our community members think about Avinger and other stocks. Vote "Outperform" if you believe AVGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVGR will underperform the S&P 500 over the long term. You may vote once every thirty days.
